{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:59:32Z","timestamp":1787021972348,"version":"build-2736575974"},"reference-count":44,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2016,2,10]],"date-time":"2016-02-10T00:00:00Z","timestamp":1455062400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0148827","type":"journal-article","created":{"date-parts":[[2016,2,10]],"date-time":"2016-02-10T14:05:38Z","timestamp":1455113138000},"page":"e0148827","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":42,"title":["An Orally Active Allosteric GLP-1 Receptor Agonist Is Neuroprotective in Cellular and Rodent Models of Stroke"],"prefix":"10.1371","volume":"11","author":[{"given":"Huinan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunhan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoyu","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinshang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xubo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shimeng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingru","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,2,10]]},"reference":[{"issue":"3","key":"ref1","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1161\/01.cir.0000442015.53336.12","article-title":"Executive summary: heart disease and stroke statistics\u20142014 update: a report from the American Heart Association","volume":"129","author":"AS Go","year":"2014","journal-title":"Circulation"},{"issue":"6","key":"ref2","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1210\/edrv.20.6.0385","article-title":"The glucagon-like peptides","volume":"20","author":"TJ Kieffer","year":"1999","journal-title":"Endocr Rev"},{"issue":"18","key":"ref3","doi-asserted-by":"crossref","first-page":"8641","DOI":"10.1073\/pnas.89.18.8641","article-title":"Expression cloning of the pancreatic beta cell receptor for the gluco-incretin hormone glucagon-like peptide 1","volume":"89","author":"B Thorens","year":"1992","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"4","key":"ref4","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1073\/pnas.0806720106","article-title":"GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism","volume":"106","author":"Y Li","year":"2009","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"8","key":"ref5","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1038\/jcbfm.2011.51","article-title":"Exendin-4, a glucagon-like peptide-1 receptor agonist, provides neuroprotection in mice transient focal cerebral ischemia","volume":"31","author":"S Teramoto","year":"2011","journal-title":"Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism"},{"issue":"5","key":"ref6","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/jcbfm.2015.17","article-title":"Glucagon-like receptor 1 agonists and DPP-4 inhibitors: potential therapies for the treatment of stroke","volume":"35","author":"V Darsalia","year":"2015","journal-title":"Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism"},{"issue":"10","key":"ref7","doi-asserted-by":"crossref","first-page":"871","DOI":"10.2165\/11635890-000000000-00000","article-title":"Potential role of glucagon-like peptide-1 (GLP-1) in neuroprotection","volume":"26","author":"C Holscher","year":"2012","journal-title":"CNS drugs"},{"issue":"9","key":"ref8","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.2337\/diab.44.9.1126","article-title":"Both subcutaneously and intravenously administered glucagon-like peptide I are rapidly degraded from the NH2-terminus in type II diabetic patients and in healthy subjects","volume":"44","author":"CF Deacon","year":"1995","journal-title":"Diabetes"},{"key":"ref9","article-title":"Glucagon-like Peptide-1 (GLP-1) Analogs: Recent Advances, New Possibilities, and Therapeutic Implications","author":"B Manandhar","year":"2014","journal-title":"Journal of medicinal chemistry"},{"issue":"1","key":"ref10","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1345\/aph.1Q379","article-title":"Clinical efficacy and safety of once-weekly glucagon-like peptide-1 agonists in development for treatment of type 2 diabetes mellitus in adults","volume":"46","author":"M Tzefos","year":"2012","journal-title":"The Annals of pharmacotherapy"},{"issue":"8","key":"ref11","doi-asserted-by":"crossref","first-page":"e103114","DOI":"10.1371\/journal.pone.0103114","article-title":"Exendin-4 reduces ischemic brain injury in normal and aged type 2 diabetic mice and promotes microglial M2 polarization","volume":"9","author":"V Darsalia","year":"2014","journal-title":"PloS one"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.brainres.2011.10.026","article-title":"Repeated administration of exendin-4 reduces focal cerebral ischemia-induced infarction in rats","volume":"1427","author":"S Briyal","year":"2012","journal-title":"Brain research"},{"issue":"7","key":"ref13","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1002\/jnr.22596","article-title":"Ischemia-induced changes in glucagon-like peptide-1 receptor and neuroprotective effect of its agonist, exendin-4, in experimental transient cerebral ischemia","volume":"89","author":"CH Lee","year":"2011","journal-title":"Journal of neuroscience research"},{"issue":"10","key":"ref14","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1042\/CS20110374","article-title":"Glucagon-like peptide-1 receptor activation reduces ischaemic brain damage following stroke in Type 2 diabetic rats","volume":"122","author":"V Darsalia","year":"2012","journal-title":"Clinical science"},{"issue":"11","key":"ref15","doi-asserted-by":"crossref","first-page":"21513","DOI":"10.3390\/ijms141121513","article-title":"Neuroprotective effects of liraglutide for stroke model of rats","volume":"14","author":"K Sato","year":"2013","journal-title":"International journal of molecular sciences"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1159\/000115190","article-title":"Impaired glucose metabolism and cerebrovascular diseases","volume":"45","author":"D Tanne","year":"2008","journal-title":"Advances in cardiology"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0306-4522(01)00396-7","article-title":"Establishment of neuronal in vitro models of ischemia in 96-well microtiter strip-plates that result in acute, progressive and delayed neuronal death","volume":"108","author":"BP Meloni","year":"2001","journal-title":"Neuroscience"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.freeradbiomed.2013.11.007","article-title":"Hypoxia-inducible factor 1 contributes to N-acetylcysteine's protection in stroke","volume":"68","author":"Z Zhang","year":"2014","journal-title":"Free Radic Biol Med"},{"issue":"8","key":"ref19","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/cns.12117","article-title":"Kir6.1 knockdown aggravates cerebral ischemia\/reperfusion-induced neural injury in mice","volume":"19","author":"YF Dong","year":"2013","journal-title":"CNS neuroscience & therapeutics"},{"issue":"6","key":"ref20","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1161\/01.STR.17.6.1304","article-title":"Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats","volume":"17","author":"JB Bederson","year":"1986","journal-title":"Stroke"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ejps.2015.01.010","article-title":"Pro-GLP-1, a Pro-drug of GLP-1, is neuroprotective in cerebral ischemia","volume":"70","author":"H Zhang","year":"2015","journal-title":"Eur J Pharm Sci"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"5531","DOI":"10.1038\/srep05531","article-title":"Nafamostat mesilate attenuates neuronal damage in a rat model of transient focal cerebral ischemia through thrombin inhibition","volume":"4","author":"T Chen","year":"2014","journal-title":"Scientific reports"},{"issue":"26","key":"ref23","doi-asserted-by":"crossref","first-page":"19650","DOI":"10.1016\/S0021-9258(19)36565-2","article-title":"Exendin-4 is a high potency agonist and truncated exendin-(9\u201339)-amide an antagonist at the glucagon-like peptide 1-(7\u201336)-amide receptor of insulin-secreting beta-cells","volume":"268","author":"R Goke","year":"1993","journal-title":"The Journal of biological chemistry"},{"issue":"11","key":"ref24","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.2337\/diab.42.11.1678","article-title":"Cloning and functional expression of the human islet GLP-1 receptor. Demonstration that exendin-4 is an agonist and exendin-(9\u201339) an antagonist of the receptor","volume":"42","author":"B Thorens","year":"1993","journal-title":"Diabetes"},{"issue":"3","key":"ref25","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1073\/pnas.0605701104","article-title":"Small-molecule agonists for the glucagon-like peptide 1 receptor","volume":"104","author":"LB Knudsen","year":"2007","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"12","key":"ref26","doi-asserted-by":"crossref","first-page":"9104","DOI":"10.3390\/molecules15129104","article-title":"Experimental models for assaying microvascular endothelial cell pathophysiology in stroke","volume":"15","author":"S Camos","year":"2010","journal-title":"Molecules"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.mcn.2012.10.001","article-title":"Tissue-type plasminogen activator protects neurons from excitotoxin-induced cell death via activation of the ERK1\/2-CREB-ATF3 signaling pathway","volume":"52","author":"F Wu","year":"2013","journal-title":"Mol Cell Neurosci"},{"issue":"1","key":"ref28","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s11011-013-9475-2","article-title":"Activation of AMP-activated protein kinase by metformin protects against global cerebral ischemia in male rats: interference of AMPK\/PGC-1alpha pathway","volume":"29","author":"G Ashabi","year":"2014","journal-title":"Metab Brain Dis"},{"issue":"2","key":"ref29","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s12640-009-9110-5","article-title":"Endoplasmic reticulum stress plays critical role in brain damage after cerebral ischemia\/reperfusion in rats","volume":"17","author":"VP Nakka","year":"2010","journal-title":"Neurotox Res"},{"issue":"10","key":"ref30","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1089\/neu.2000.17.899","article-title":"Apoptosis after experimental stroke: fact or fashion?","volume":"17","author":"JP MacManus","year":"2000","journal-title":"J Neurotrauma"},{"issue":"Pt 1","key":"ref31","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/brain\/awh645","article-title":"Apoptosis dominant in the periinfarct area of human ischaemic stroke\u2014a possible target of antiapoptotic treatments","volume":"129","author":"T Sairanen","year":"2006","journal-title":"Brain"},{"issue":"6","key":"ref32","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1053\/j.gastro.2007.03.054","article-title":"Biology of incretins: GLP-1 and GIP","volume":"132","author":"LL Baggio","year":"2007","journal-title":"Gastroenterology"},{"issue":"7","key":"ref33","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0165-6147(03)00160-3","article-title":"The glucagon-like peptides: a double-edged therapeutic sword?","volume":"24","author":"T Perry","year":"2003","journal-title":"Trends Pharmacol Sci"},{"issue":"6","key":"ref34","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S1359-6446(05)03370-2","article-title":"Mechanisms of peptide and nonpeptide ligand binding to Class B G-protein-coupled receptors","volume":"10","author":"SR Hoare","year":"2005","journal-title":"Drug Discov Today"},{"issue":"4","key":"ref35","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1210\/en.2013-1934","article-title":"GLP-1 receptor localization in monkey and human tissue: novel distribution revealed with extensively validated monoclonal antibody","volume":"155","author":"C Pyke","year":"2014","journal-title":"Endocrinology"},{"issue":"1","key":"ref36","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1210\/en.2012-1937","article-title":"GLP-1 receptor activation indirectly reduces hepatic lipid accumulation but does not attenuate development of atherosclerosis in diabetic male ApoE(-\/-) mice","volume":"154","author":"N Panjwani","year":"2013","journal-title":"Endocrinology"},{"issue":"1","key":"ref37","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1210\/en.2012-2124","article-title":"The glucagon-like peptide-1 receptor\u2014or not?","volume":"154","author":"C Pyke","year":"2013","journal-title":"Endocrinology"},{"issue":"8","key":"ref38","doi-asserted-by":"crossref","first-page":"770","DOI":"10.7150\/thno.7759","article-title":"(64)Cu labeled sarcophagine exendin-4 for microPET imaging of glucagon like peptide-1 receptor expression","volume":"4","author":"Z Wu","year":"2014","journal-title":"Theranostics"},{"issue":"8","key":"ref39","doi-asserted-by":"crossref","first-page":"e44284","DOI":"10.1371\/journal.pone.0044284","article-title":"Glucagon like peptide-1-induced glucose metabolism in differentiated human muscle satellite cells is attenuated by hyperglycemia","volume":"7","author":"CJ Green","year":"2012","journal-title":"PloS one"},{"issue":"1","key":"ref40","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/aps.2011.149","article-title":"Glucagon-like peptide-1 activates endothelial nitric oxide synthase in human umbilical vein endothelial cells","volume":"33","author":"L Ding","year":"2012","journal-title":"Acta pharmacologica Sinica"},{"issue":"1","key":"ref41","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00894-008-0372-2","article-title":"Molecular modeling of the three-dimensional structure of GLP-1R and its interactions with several agonists","volume":"15","author":"F Lin","year":"2009","journal-title":"Journal of molecular modeling"},{"issue":"12","key":"ref42","doi-asserted-by":"crossref","first-page":"10195","DOI":"10.1074\/jbc.M212147200","article-title":"The isolated N-terminal domain of the glucagon-like peptide-1 (GLP-1) receptor binds exendin peptides with much higher affinity than GLP-1","volume":"278","author":"R Lopez de Maturana","year":"2003","journal-title":"The Journal of biological chemistry"},{"issue":"5","key":"ref43","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.3171\/2012.11.JNS12408","article-title":"The science of cerebral ischemia and the quest for neuroprotection: navigating past failure to future success","volume":"118","author":"RC Turner","year":"2013","journal-title":"Journal of neurosurgery"},{"issue":"9","key":"ref44","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1179\/174313209X382449","article-title":"Insulin activates the PI3K-Akt survival pathway in vulnerable neurons following global brain ischemia","volume":"31","author":"TH Sanderson","year":"2009","journal-title":"Neurological research"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0148827","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T17:43:36Z","timestamp":1654278216000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0148827"}},"subtitle":[],"editor":[{"given":"Muzamil","family":"Ahmad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,2,10]]},"references-count":44,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2016,2,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0148827","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,10]]}}}